{"name":"Shaheed Mohtarma Benazir Bhutto Institue of Trauma","slug":"shaheed-mohtarma-benazir-bhutto-institue-of-trauma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Adrenaline nasal pack","genericName":"Adrenaline nasal pack","slug":"adrenaline-nasal-pack","indication":"Anaphylaxis treatment","status":"phase_2"},{"name":"Group B : Conventional Dose","genericName":"Group B : Conventional Dose","slug":"group-b-conventional-dose","indication":"Other","status":"phase_1"},{"name":"Intravenous Dexmedetomidine infusion","genericName":"Intravenous Dexmedetomidine infusion","slug":"intravenous-dexmedetomidine-infusion","indication":"Other","status":"marketed"},{"name":"Intravenous Lignocain","genericName":"Intravenous Lignocain","slug":"intravenous-lignocain","indication":"Local anesthesia","status":"phase_2"}]}],"pipeline":[{"name":"Adrenaline nasal pack","genericName":"Adrenaline nasal pack","slug":"adrenaline-nasal-pack","phase":"phase_2","mechanism":"Adrenaline nasal pack works by releasing adrenaline into the nasal passages to rapidly increase blood pressure and improve breathing in cases of anaphylaxis or severe allergic reactions.","indications":["Anaphylaxis treatment"],"catalyst":""},{"name":"Group B : Conventional Dose","genericName":"Group B : Conventional Dose","slug":"group-b-conventional-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intravenous Dexmedetomidine infusion","genericName":"Intravenous Dexmedetomidine infusion","slug":"intravenous-dexmedetomidine-infusion","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intravenous Lignocain","genericName":"Intravenous Lignocain","slug":"intravenous-lignocain","phase":"phase_2","mechanism":"Blocks sodium channels","indications":["Local anesthesia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNSzZ0MHowQVFLaDdid05iYWJMLUxFSERCaWM4VFpyUnNocGZub1RjM2xGd0x6NF9TU0hiQ09faGJWUmtNYWlCRFlnYnoxcGpnSE9XendLNm9pREl0VGRDbjgzN21MUF9HNkFNVW5LM3RlMy1pZHg1a2VQOHZaWHlRYzloQUVha3VEWmJnb1N0dWdJMXFiU0lRejdEV2JFWm1RMUptbXhvOTd5VkljZDEySVRnQnRQdw?oc=5","date":"2018-12-06","type":"pipeline","source":"Daily Times","summary":"The SMBB Trauma Centre stands tall as a hallmark public sector health institution - Daily Times","headline":"The SMBB Trauma Centre stands tall as a hallmark public sector health institution","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_2":2,"phase_1":1,"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}